A
$ Value
$0
Shares
24,060
Price
$0
Filed
Jan 5
Insider
Name
Guerrero Ramiro
Title
—
CIK
0001913253
Roles
Director
Transaction Details
Transaction Date
2025-12-31
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
24,060
Footnotes
The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Filing Info
Guerrero Ramiro's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | MAIA | A | $0 |
| 2025-12-31 | MAIA | A | $0 |
| 2025-10-02 | MAIA | A | $0 |
| 2025-06-30 | MAIA | A | $0 |
| 2025-05-08 | MAIA | ▲ | $30K |
| 2025-05-08 | MAIA | ▲ | $41K ★ |
Other Insiders at MAIA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CHAOUKI STEVEN M | — | — | 2026-03-31 |
| Smith Stan | — | — | 2026-03-31 |
|
Gryaznov Sergei
Chief Scientific Officer
|
— | — | 2026-04-10 |
| Guerrero Ramiro | — | — | 2026-03-31 |
|
Vitoc Vlad
Chief Executive Officer
|
— | — | 2026-04-10 |
| Louie Ngar Yee | — | — | 2026-03-31 |
| Luput Cristian | — | — | 2026-03-31 |
| Theagene Jean-Manasse | — | — | 2026-03-31 |
|
Himmelreich Jeffrey C
Head of Finance
|
— | — | 2026-04-10 |